Sharp Uptick in Gender-Affirming Hormone Therapy Visits After ACA’s Passage
Healthcare visits for transgender-related diagnoses and gender-affirming hormone therapy (GAHT) have been rising, researchers reported, suggesting it as an opportunity for HIV prevention. Within a commercial health plan database, the proportion of adults with a transgender-related diagnosis code increased by 30.8% each year from 2014 to 2021 (13.4 to 113.9 per 100,000 enrolled persons) for […]